India & Novo Nordisk
6 shared events · Importance 3 · Last updated Apr 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
India: India is a key battleground for weight-loss drugs due to its large obesity population and is experiencing significant competition between Novo Nordisk and Eli Lilly and Company.
Novo Nordisk: Novo Nordisk cut the price of its weight-loss drug Semaglutide in India to compete with Eli Lilly and prepare for generic competition, aiming to increase market share and accessibility.
Nov 11, 2025 · 6 articles
Business
India: India is the location where Biopharmaceutical, the company providing the manufacturing services, is based and where the services will be provided.
Novo Nordisk: Novo Nordisk is outsourcing cartridge fill-finish manufacturing services to Biopharmaceutical, which could streamline its production and supply chain.
Jun 30, 2026 · 6 articles
Business
Novo Nordisk: Novo Nordisk partnered with Emcure Pharma to expand the distribution and marketing of its weight-loss drug semaglutide in India under the brand Poviztra, aiming to reach a wider population.
Nov 10, 2025 · 6 articles
NEWSDESK
Explore this relationship live
Track how India and Novo Nordisk interact across events, view sentiment trends, and discover connected entities.
Open Dashboard